WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 70.60
-0.10 (-0.14%)
At close: Jul 9, 2026
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.21 billion as of July 9, 2026. Its market cap has increased by 18.26% in one year.
Market Cap
3.21B
Enterprise Value
3.70B
Revenue
1.14B
Ranking
n/a
PE Ratio
15.30
Stock Price
70.60
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.21B, a decrease of -6.40%. That is a compound annual growth rate of -2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.21B | -3.81% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.91B |
| Hi-Clearance | 5.77B |
| Bonraybio | 2.93B |
| A Plus Biotechnology | 2.53B |
| Wellell | 2.37B |
| Applied BioCode | 2.34B |
| Medimaging Integrated Solution | 2.33B |
| OK Biotech | 2.22B |